Join

Compare · RCKT vs RKT

RCKT vs RKT

Side-by-side comparison of Rocket Pharmaceuticals Inc. (RCKT) and Rocket Companies Inc. (RKT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • RCKT operates in Health Care, while RKT operates in Finance - the two are in different parts of the market.
  • RKT is the larger of the two at $37.74B, about 99.9x RCKT ($377.8M).
  • Over the past year, RCKT is up 31.1% and RKT is down 9.1% - RCKT leads by 40.2 points.
  • RKT has been more active in the news (18 items in the past 4 weeks vs 2 for RCKT).
  • Both have 25 recent analyst ratings on file.
PerformanceRCKT+31.12%RKT-9.12%
2025-06-23+0.00%2026-06-22
MetricRCKTRKT
Company
Rocket Pharmaceuticals Inc.
Rocket Companies Inc.
Price
$3.46+3.44%
$13.35-7.42%
Market cap
$377.8M
$37.74B
1M return
+16.72%
-2.13%
1Y return
+31.12%
-9.12%
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Exchange
NASDAQ
NYSE
IPO
2015
2020
News (4w)
2
18
Recent ratings
25
25
RCKT

Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has four clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia; and infantile malignant osteopetrosis, a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO Inc. The company also has a research and collaboration agreement with Lund University; and strategic collaboration agreement with Stanford University School of Medicine. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.

RKT

Rocket Companies Inc.

Rocket Companies, Inc. engages in the tech-driven real estate, mortgage, and eCommerce businesses in the United States and Canada. It operates in two segments, Direct to Consumer and Partner Network. The company's solutions include Rocket Mortgage, a mortgage lender; Amrock that provides title insurance, property valuation, and settlement services; Rocket Homes, a home search platform and real estate agent referral network, which offers technology-enabled services to support the home buying and selling experience; Rocket Auto, an automotive retail marketplace that provides centralized and virtual car sales support to national car rental and online car purchasing platforms; and Rocket Loans, an online-based personal loans business. Its solutions also include Core Digital Media, a digital social and display advertiser in the mortgage, insurance, and education sectors; Nexsys, a fintech company, which offers a suite of essential tech solutions for mortgage origination and closing processes through digitization and automation; Lendesk, a technology services company that provides a point of sale system for mortgage professionals and a loan origination system for private lenders; and Edison Financial, a digital mortgage startup. In addition, the company originates, closes, sells, and services agency-conforming loans. Rocket Companies, Inc. was founded in in 1985 and is headquartered in Detroit, Michigan. Rocket Companies, Inc. is a subsidiary of Rock Holdings, Inc.

Latest RCKT

Latest RKT